CareLit · DOI-Nachweis · Pneumologie
Tiotropium Respimat: Comparison of bronchodilator efficacy of 5 and 2.5 µg doses
DOI 10.1055/s-0035-1544635
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Hohlfeld, P Calverley, M Könen-Bergmann, N Metzdorf, S Bell
ZeitschriftPneumologie
Ausgabe02/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Safety and efficacy of tiotropium Respimat 5 µg (R5) and 2.5 µg (R2.5) doses were compared with tiotropium HandiHaler 18 µg (HH) in two recent chronic obstructive pulmonary disease (COPD) trials. Aims and objectives: To compare bronchodilator efficacy of once-daily R5 and R2.5 and HH in TIOtropium Safety and Performance In Respimat (TIOSPIR; NCT01126437)1 and the 205.458 (NCT01222533)2 trials. Methods: T…
Zitieren
Zitierempfehlung
J Hohlfeld, P Calverley, M Könen-Bergmann, N Metzdorf, S Bell (2015) Tiotropium Respimat: Comparison of bronchodilator efficacy of 5 and 2.5 µg doses. Pneumologie (02). https://doi.org/10.1055/s-0035-1544635
Mit CareLit weiterarbeiten